HSE to shave tens of millions off drug bill with launch of cheaper alternative

Huilo is the new drug that has been launched

Mylan has launched a new drug that will result in significant price savings on the state’s €124 million annual bill for Humira, which the HSE spends more on than any other drug on the market.

Humira, a biological drug that is manufactured by AbbVie, is predominantly used to treat rheumatoid arthritis, but also Crohn’s disease, colitis and psoriasis. The HSE pays approximately €1,080 per month for a dose of Humira (80mg), but that ...